--- canonical_name: Insoles alternate_names: Shoe Inserts, Shoe Insoles, Orthotics, Foot Orthoses, Foot Orthotics, Orthotic Insoles, Custom Foot Orthoses, Prefabricated Foot Orthoses, Arch Supports, Footbeds, Lateral Wedge Insoles, Heel Lifts, Heel Cups canonical_topic: Insoles for Health & Longevity short_topic_lc: insoles creation_date: 2026-0929-1345 creator_ai_fullname: Opus 5.5 ep_keywords: Orthopedic Devices, Podiatric Devices, Footwear --- # Insoles for Health & Longevity
Evidence Review created on 09/29/2026 using [AI4L](https://github.com/forever-healthy/AI4L) / Opus 5.5 **Also known as:** Shoe Inserts, Shoe Insoles, Orthotics, Foot Orthoses, Foot Orthotics, Orthotic Insoles, Custom Foot Orthoses, Prefabricated Foot Orthoses, Arch Supports, Footbeds, Lateral Wedge Insoles, Heel Lifts, Heel Cups ## Motivation Insoles are removable layers placed inside shoes to cushion, support or reshape how the foot meets the ground. They range from inexpensive off-the-shelf arch supports to custom devices molded to an individual foot, and they are among the most widely used tools for foot, knee and lower-leg complaints. Their appeal for healthy aging is straightforward: the feet carry every step of an active life, and foot pain, foot wounds and unsteady balance can quietly shrink how much a person moves. Insoles have been studied in three areas that matter to an active, aging adult: painful feet and knees, protection of the feet in people with diabetes-related nerve damage, and balance in later life. At the same time, custom devices can be costly, and some movement specialists argue that heavy reliance on support leaves the foot itself weaker. This review examines what controlled research shows about the benefits, risks and practical use of insoles, how custom and off-the-shelf devices compare, and where the evidence remains uncertain. **[Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol) - [Conclusion](#conclusion)** ## Recommended Reading A curated selection of expert commentary and narrative articles that give a high-level overview of insoles and foot orthoses. * [#296 ‒ Foot health: preventing and treating common injuries, enhancing strength and mobility, picking footwear, and more – Courtney Conley, D.C.](https://peterattiamd.com/courtneyconley/) - Peter Attia Foot and gait (walking pattern) specialist Courtney Conley contrasts the orthotic-lab habit of placing support under painful feet with strength- and mobility-based foot care, including falls and footwear choices in aging. * [RHR: Focus on Your Feet to Live Pain Free and Be a Better Athlete, with Graham Tuttle](https://chriskresser.com/focus-on-your-feet-to-live-pain-free-and-be-a-better-athlete-with-graham-tuttle/) - Chris Kresser A strength coach presents the skeptical case against routine orthotic use, describing a gradual transition away from orthotics toward flexible, wide footwear and foot strengthening. * [Foot orthoses: how much customisation is necessary?](https://pubmed.ncbi.nlm.nih.gov/19589160/) - Menz, 2009 A podiatry (foot and ankle medicine) researcher argues that prefabricated orthoses may match custom devices for some conditions; notable because it comes from within the profession that sells custom orthoses. * [Running shoes and running injuries: mythbusting and a proposal for two new paradigms: 'preferred movement path' and 'comfort filter'](https://pubmed.ncbi.nlm.nih.gov/26221015/) - Nigg et al., 2015 A biomechanics review questioning whether cushioning and pronation (inward roll of the foot) control prevent injury, proposing instead that comfortable shoes and inserts preserve each runner's natural movement path. * [The Role of Pressure Offloading on Diabetic Foot Ulcer Healing and Prevention of Recurrence](https://pubmed.ncbi.nlm.nih.gov/27556758/) - Bus, 2016 Reviews how relieving high plantar (sole-of-foot) pressure, called offloading, heals and prevents diabetic foot ulcers, emphasizing pressure-verified custom footwear and insoles and the decisive role of wearing them. Content from Andrew Huberman, Rhonda Patrick (FoundMyFitness), Life Extension Magazine and Lifespan.io is not listed: on-site and web searches of these platforms found no article or episode that discusses insoles or foot orthoses in substantive depth, only incidental mentions or no results. ## Grokipedia [Shoe insert](https://grokipedia.com/page/Shoe_insert) A broad overview of insole types, materials, prefabricated versus custom devices, history, and uses in diabetes, sport and older adults; several benefit claims go beyond the controlled-trial evidence reviewed here. ## Examine No Examine article on insoles exists; Examine.com focuses on supplements and nutrition and has no page on insoles, foot orthoses or other footwear devices. ## ConsumerLab No ConsumerLab article on insoles exists; ConsumerLab tests supplements and related consumer products, and its only related hit is an answer about supplements for plantar fasciitis (heel pain) rather than about insoles. ## Systematic Reviews Five systematic reviews and meta-analyses covering the main uses of insoles and their principal trade-off. * [Foot orthoses for plantar heel pain: a systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/28935689/) - Whittaker et al., 2018 Nineteen trials (1,660 people) of heel pain: small pain benefit versus sham (placebo-like) devices at 7–12 weeks only; custom equaled prefabricated. Authors are podiatry researchers. * [Effectiveness of foot orthoses and shock-absorbing insoles for the prevention of injury: a systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/27919918/) - Bonanno et al., 2017 Eighteen trials, mostly military: orthoses cut overall injuries by about a quarter and stress fractures (overuse bone cracks) by about 40%; cushioning insoles did not. * [Lateral wedge insoles as a conservative treatment for pain in patients with medial knee osteoarthritis: a meta-analysis](https://pubmed.ncbi.nlm.nih.gov/23989797/) - Parkes et al., 2013 Twelve trials (885 people): outward-tilted (lateral wedge) insoles gave no meaningful knee-pain benefit over neutral insoles in inner-knee (medial) osteoarthritis. * [Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data](https://pubmed.ncbi.nlm.nih.gov/31773194/) - Crawford et al., 2020 Twenty-two randomized controlled trials (RCTs, treatment assigned by chance): custom footwear with offloading insoles roughly halved foot-ulcer risk in diabetes. * [The effect of foot orthoses and insoles on running economy and performance in distance runners: A systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/31423908/) - Crago et al., 2019 Represents the principal trade-off: orthoses slightly raised running's oxygen cost. No systematic review focuses on discomfort or skin problems, the commonest harms. ## Mechanism of Action Insoles are mechanical devices, so nothing is absorbed or cleared by the body: effects begin when they are worn and stop when they are removed. They act at the foot–ground interface in four ways: * **Pressure redistribution:** contoured and cushioned insoles spread load from high-pressure spots such as the heel and metatarsal heads (the bones at the ball of the foot); pressure-optimized diabetic insoles lower peak plantar pressure by roughly 20% or more, easing repetitive tissue stress in feet with neuropathy (nerve damage that removes protective sensation) ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)). * **Altered joint loading:** arch supports and medial posts (inner-edge wedges) may lower tibialis posterior (arch-supporting calf muscle) activity during walking ([Reeves et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31547793/)); lateral wedges slightly lower the external knee adduction moment, a gait measure of load on the inner knee ([Arnold et al., 2016](https://pubmed.ncbi.nlm.nih.gov/26605535/)). * **Shock attenuation:** soft materials absorb impact, although cushioning alone has not prevented injury in trials. * **Sensory stimulation:** textured, raised or vibrating surfaces excite plantar mechanoreceptors (pressure-sensing nerve endings) that age and neuropathy dull; vibration may act through stochastic resonance (low-level noise that makes weak signals easier to detect). A competing explanation holds that kinematic (joint motion) changes are small and inconsistent between individuals, and sham insoles often produce sizeable improvements, so comfort, expectation and natural recovery may explain much of the effect. Nigg's "comfort filter" model ([Nigg et al., 2015](https://pubmed.ncbi.nlm.nih.gov/26221015/)) proposes that insoles help by letting each person keep a preferred movement path rather than by correcting alignment. ## Historical Context & Evolution Shoe inserts began as comfort and corrective devices. In the late 19th century, orthopedic surgeon Royal Whitman introduced a rigid metal plate to support painful flat feet, and in the early 20th century William Scholl commercialized mass-market arch supports. From the 1960s, podiatrist Merton Root's model of "subtalar neutral" alignment (a theoretically ideal position of the joint below the ankle) made casted, custom functional orthoses the professional standard, on the premise that correcting foot posture prevents injury further up the leg. Interest for health optimization came from three directions: military and sports medicine seeking to prevent stress fractures, diabetes care seeking to prevent ulcers and amputations (formalized in the United States by Medicare's therapeutic shoe benefit in 1993), and gerontology (the study of aging) seeking better balance as foot sensation declines. From the 2000s, trials using sham insoles and prefabricated comparators changed the picture. Custom devices often performed no better than prefabricated ones; larger, better-blinded trials of lateral wedges for knee arthritis found smaller effects than early unblinded studies; and pressure-guided diabetic insoles gained trial support. Research on minimalist footwear (thin, flexible, flat shoes) and foot strengthening has since advanced a competing view that feet benefit from load rather than support. Neither view is settled, and both are being tested in ongoing trials that could shift the balance in either direction. ## Expected Benefits ### High 🟩 🟩 🟩 #### Prevention of recurrent diabetic foot ulcers Pressure-relieving insoles, alone or within custom footwear, reduce the repeated sole pressure that causes ulcers in feet numbed by peripheral neuropathy. A meta-analysis of randomized trials found custom footwear with offloading insoles reduced ulceration ([Crawford et al., 2020](https://pubmed.ncbi.nlm.nih.gov/31773194/)), and a multicenter trial of shape- and pressure-based insoles cut forefoot ulcer recurrence ([Ulbrecht et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24760263/)); its authors were affiliated with the insoles' maker. Benefit depends on daily wear: another trial found an effect only among adherent wearers ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)). Ulcers precede most diabetes-related amputations. **Magnitude:** Risk ratio (risk with treatment divided by risk without) 0.53 (95% confidence interval, the range likely to contain the true value, 0.33–0.85) for ulceration; among adherent wearers, recurrence was 25.7% versus 47.8% over 18 months. #### Relief of foot pain In plantar heel pain (often called plantar fasciitis), orthoses outperformed sham devices only at 7–12 weeks, and custom devices equaled prefabricated ones ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)); a second meta-analysis likewise found no short-term superiority ([Rasenberg et al., 2018](https://pubmed.ncbi.nlm.nih.gov/29555795/)). In rheumatoid arthritis (autoimmune joint inflammation), pooled trials showed pain relief without disability change ([Conceição et al., 2015](https://pubmed.ncbi.nlm.nih.gov/25249238/)), and in painful high-arched (cavus) feet custom orthoses beat sham insoles at 3 months ([Burns et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16707631/)). Bunion pain data are low certainty ([Hurn et al., 2022](https://pubmed.ncbi.nlm.nih.gov/33768721/)). Effects are small and time-limited. **Magnitude:** Standardized mean difference (effect size in standard-deviation units; 0.2 is small) −0.27 (−0.48 to −0.06) for heel pain at 7–12 weeks versus sham; weighted mean difference (average between-group difference, weighted by study size) 0.40 (0.04–0.57) in pain favoring orthoses in rheumatoid arthritis; foot pain improved 8.3 points more (0–100 scale; 1.2–15.3) with custom orthoses than sham in cavus feet. ### Medium 🟩 🟩 #### Short-term relief of patellofemoral pain Patellofemoral pain (pain around or behind the kneecap) improved more with prefabricated foot orthoses than with flat inserts at six weeks in a randomized trial of 179 adults, although orthoses matched physiotherapy and added nothing to it ([Collins et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18952682/)). A later meta-analysis rated orthoses effective for short-term global improvement, but its estimate rests on this same trial's data ([Neal et al., 2022](https://pubmed.ncbi.nlm.nih.gov/36070427/)). No benefit has been shown beyond three months, and all groups improved over a year. **Magnitude:** Odds ratio (odds of improving with orthoses relative to comparison) 4.31 (1.48–12.56) for global improvement at up to three months; number needed to treat (people treated for one extra success) of 4 at six weeks. #### Better balance and fewer falls in older adults Insoles with arch support or raised textures stimulate sole sensation; a meta-analysis of 18 studies in older adults found reduced postural sway (small body movements while standing) and faster Timed Up and Go times (rising, walking three meters, returning, sitting), mostly as immediate effects ([Jor et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40998603/)); one author works for an orthotics company. A 305-person trial of a podiatry program including orthoses, footwear advice and exercises reduced falls ([Spink et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21680622/)), but the insoles' own contribution cannot be isolated. **Magnitude:** Timed Up and Go improved by 1.15 seconds (0.47–1.82); the multifaceted program produced 36% fewer falls (incidence rate ratio, the ratio of fall rates between groups, 0.64; 0.45–0.91). #### Achilles tendon pain relief with heel lifts In mid-portion Achilles tendinopathy (painful degeneration of the heel cord), in-shoe heel lifts outperformed eccentric calf exercise (slow lowering under load) at 12 weeks in a 100-person randomized trial by a podiatry research group ([Rabusin et al., 2021](https://pubmed.ncbi.nlm.nih.gov/32988930/)). The difference approached but did not reach the prespecified clinically important threshold. Evidence rests on this single trial. **Magnitude:** Victorian Institute of Sport Assessment–Achilles score (a 0–100 pain and function scale) improved 9.6 points more with heel lifts (1.8–17.4). ### Low 🟩 #### Fewer overuse injuries and stress fractures ⚠️ Conflicted Foot orthoses (contoured, supportive insoles) lowered injuries and stress fractures in a meta-analysis of 11 mostly military trials ([Bonanno et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27919918/)). A later meta-analysis of 22 military trials found no protective effect ([Paradise et al., 2024](https://pubmed.ncbi.nlm.nih.gov/34785586/)). Differing trial selection may explain this. Net reading: protection is plausible but unconfirmed. **Magnitude:** Risk ratio 0.72 (0.55–0.94) for overall injury and 0.59 (0.45–0.76) for stress fractures with foot orthoses in the 2017 meta-analysis; the 2024 pooled analysis showed no reduction. #### Medial knee osteoarthritis pain ⚠️ Conflicted In inner-knee cartilage wear, lateral wedge insoles showed benefit only against no insole; against neutral insoles the effect vanished ([Parkes et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23989797/)), and a 12-month trial found no pain or cartilage benefit ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)). Net reading: no reliable benefit over neutral insoles. **Magnitude:** Standardized mean difference −0.03 (−0.18 to 0.12) versus neutral insoles, equal to 0.12 points on the 20-point WOMAC (Western Ontario and McMaster Universities Arthritis Index) pain scale. #### Chronic low back pain ⚠️ Conflicted Earlier meta-analyses found insoles neither treated nor prevented low back pain ([Chuter et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24775807/); [Steffens et al., 2016](https://pubmed.ncbi.nlm.nih.gov/26752509/)). A 2026 meta-analysis reported reduced pain and disability ([Lin et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40844962/)); its newer, heterogeneous trials and low certainty may explain this. Net reading: prevention is unsupported; treatment benefit is uncertain. **Magnitude:** Prevention risk ratio 1.01 (0.74–1.40) in the 2016 meta-analysis; treatment standardized mean difference −0.74 (−1.5 to 0.03) in the 2014 pooled trials. ### Speculative 🟨 #### Sustaining walking and activity volume By easing foot and knee pain, insoles could help active adults keep walking and training into later life. The basis is mechanistic only: no identified trial has measured long-term physical activity. ## Benefit-Modifying Factors * **Genetic polymorphisms:** No gene variants are known to modify insole response; inherited foot shape (high or flat arches) and joint laxity (unusually loose joints) influence which design fits, but no genetic test guides selection. * **Baseline biomarkers:** Loss of protective sensation (a missed 10 g monofilament, a standardized nylon filament) and high in-shoe peak pressure identify diabetic feet with most to gain; better glycemic control (HbA1c, average blood sugar over three months) slows neuropathy. * **Sex differences:** Trials rarely analyze sex separately; women are well represented in heel pain and patellofemoral pain trials, and narrow fashion footwear limits insole fit, which may blunt benefit outside athletic shoes. * **Pre-existing conditions:** Diabetic neuropathy, rheumatoid arthritis and painful heel or kneecap conditions show the clearest benefits; medial knee osteoarthritis gains little from lateral wedges, although people with high inner-knee loading may respond better. * **Age:** Older adults, whose sole sensation and heel fat padding decline, may gain more from firm or textured insoles for balance and heel cups for fat-pad thinning; soft, thick cushioning may worsen their standing balance. * **Body weight:** Higher body weight raises plantar loading and heel pain risk, so pressure redistribution may matter more, while weight loss can reduce the load insoles must manage. ## Potential Risks & Side Effects ### High 🟥 🟥 🟥 #### Skin irritation, blisters and device discomfort The commonest problems are rubbing, blistering, pressure points and toe, foot or ankle pain, usually in the first weeks of wear. In a patellofemoral pain trial, mild side effects were far more frequent with orthoses than flat inserts and mostly resolved with adjustment ([Collins et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18952682/)). In a knee osteoarthritis trial, lateral wedges caused more back and foot pain, poorer comfort and shorter daily wear ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)). Risk rises with numb or fragile skin. **Magnitude:** Mild side effects in 72% with orthoses versus 38% with flat inserts; problems in 47% with lateral wedges versus 23% with flat insoles, with severe discomfort in 10% versus 1%. #### Reduced running economy Foot orthoses add mass and alter foot mechanics, raising running economy costs (oxygen used at a given pace) in a meta-analysis of nine studies ([Crago et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31423908/)). Shock-absorbing insoles showed a similar but imprecise effect. The penalty is small and matters mainly for competitive endurance performance rather than health. **Magnitude:** Standardized mean difference 0.42 (0.17–0.72) for worse running economy with foot orthoses; 0.26 (−0.33 to 0.84) for shock-absorbing insoles. ### Medium 🟥 🟥 #### Impaired standing balance with soft insoles In a crossover trial (each participant tested every condition) of 150 healthy adults aged over 65, soft insoles worsened postural control compared with barefoot standing and hard insoles, and hard insoles did not improve on barefoot balance ([Martínez-Córcoles et al., 2024](https://pubmed.ncbi.nlm.nih.gov/39768094/)). The effect was measured during quiet standing, not as falls. Soft, thick cushioning may dampen sole sensation. **Magnitude:** Sway area (the area covered by body sway while standing) was 182 versus 123 with soft versus hard insoles with eyes open and 208 versus 139 with eyes closed, standardized effect sizes of 1.01 and 1.08; falls were not measured. ### Low 🟥 #### Intrinsic foot muscle deconditioning ⚠️ Conflicted Critics argue arch support offloads, and so weakens, the small muscles inside the foot. Indirect evidence: minimalist-shoe walking strengthened these muscles ([Ridge et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30113521/)), yet orthoses alone enlarged abductor hallucis (big-toe muscle) in one trial ([Jung et al., 2011](https://pubmed.ncbi.nlm.nih.gov/22142711/)). Net reading: weakening is unproven. **Magnitude:** Not quantified in available studies. No identified trial has compared foot muscle strength or size between long-term insole users and non-users. #### Load transfer to the ankle and hip with lateral wedges Tilting the foot outward to unload the inner knee could shift stress to the ankle or hip. In a 36-month randomized trial, hip and ankle joint space (cartilage thickness on X-ray) did not differ between lateral wedge and neutral insoles, but most participants dropped out ([Tezcan et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27693959/)). **Magnitude:** Joint space in the hip on the treated side narrowed 0.38 mm with lateral wedges versus 0.31 mm with neutral insoles over 36 months, a non-significant difference, with no ankle differences, among 45 completers of 109 enrolled. ### Speculative 🟨 ## Risk-Modifying Factors * **Genetic polymorphisms:** No gene variants are known to alter insole side effects; inherited joint laxity or rigid high arches can make aggressive arch contours uncomfortable. * **Baseline biomarkers:** Loss of protective sensation, poor glycemic control and an ankle-brachial index (ankle-to-arm blood pressure ratio, a circulation marker) below 0.9 raise the chance that a rubbing insole produces an unnoticed wound. * **Sex differences:** No sex-specific adverse-event data exist; narrow, low-volume fashion footwear, more common among women, crowds insoles and raises pressure and blister risk. * **Pre-existing conditions:** Diabetic neuropathy, peripheral arterial disease (narrowed leg arteries), rheumatoid arthritis with fragile skin and Charcot foot (nerve-related collapse of foot bones) raise injury risk from ill-fitting devices. * **Age:** Older adults have thinner skin, slower healing and reduced sole sensation, and soft cushioned insoles impaired their standing balance in trial data ([Martínez-Córcoles et al., 2024](https://pubmed.ncbi.nlm.nih.gov/39768094/)). ## Key Interactions & Contraindications * **Neuropathy-causing prescription drugs:** Caution. No direct interaction, but chemotherapy agents (paclitaxel, oxaliplatin, vincristine) blunt sole sensation, so insole blisters can progress unnoticed to ulcers; daily foot inspection and gradual break-in mitigate this. * **Anticoagulants and corticosteroids:** Monitor. Anticoagulants (blood thinners: warfarin, apixaban) and long-term oral corticosteroids (anti-inflammatory steroid drugs: prednisone) increase skin fragility, bruising and slow healing of device-related blisters; shorter initial wear periods and skin checks mitigate this. * **Over-the-counter medications:** Caution. Regular analgesics (pain relievers: ibuprofen, naproxen, acetaminophen) can mask device-related pain, delaying recognition of pressure points; reviewing fit and skin during the first weeks mitigates this. * **Supplements:** No interaction or additive effect with insoles has been identified in trials; supplements promoted for heel or joint pain (collagen, glucosamine, curcumin) have separate, limited evidence and no known effect on insole response. * **Physiotherapy and exercise:** Monitor. Orthoses added nothing to physiotherapy for patellofemoral pain in one trial ([Collins et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18952682/)), so combined use may duplicate effort without extra benefit; reassessing at 6 weeks identifies redundant components. * **Footwear:** Caution. Insoles in shallow or narrow shoes raise pressure and blister risk; shoes with removable liners and adequate depth mitigate this. **Populations who should avoid Insoles:** * People with an active plantar ulcer, which requires clinician-directed offloading (for example a total contact cast) rather than standard insoles * People with active Charcot foot (a warm, swollen foot with skin temperature more than 2 °C above the other foot), which requires immobilization * People with critical limb ischemia (severely reduced leg blood flow: ankle-brachial index below 0.5 or rest pain), for whom rigid devices risk pressure injury outside specialist care * For lateral wedges: people with outer-knee (lateral compartment) osteoarthritis or valgus (knock-knee) alignment, where outward tilting adds load to the diseased side * For soft, thick cushioned insoles: older adults at high fall risk (Timed Up and Go of 13.5 seconds or more) without a balance assessment ## Risk Mitigation Strategies * **Gradual break-in:** Protocols typically start with 1–2 hours of wear on day one, adding about an hour daily over 1–2 weeks, which reduces blisters, pressure points and foot or ankle pain. * **Daily skin inspection in numb feet:** Checking both soles for redness lasting more than 30 minutes after removal, blisters or calluses prevents unnoticed device injuries from progressing to ulcers. * **Pressure-verified diabetic prescription:** In-shoe pressure measurement targets peak pressures below about 200 kPa (kilopascals, a pressure unit) or at least 25% reduction at previous ulcer sites, lowering recurrence risk ([Bus, 2016](https://pubmed.ncbi.nlm.nih.gov/27556758/)). * **Firm rather than soft cushioning for balance:** Firmer contoured insoles instead of soft, thick foam avoid the standing-balance impairment seen with soft insoles in adults over 65 ([Martínez-Córcoles et al., 2024](https://pubmed.ncbi.nlm.nih.gov/39768094/)). * **Adequate shoe volume:** Removing the factory liner and using shoes with enough depth prevents crowding, which causes blisters and toe pain. * **Foot strengthening alongside insoles:** Toe-spreading, short-foot exercise (drawing the ball of the foot toward the heel to raise the arch) and calf raises 3–5 times weekly counter possible foot muscle deconditioning. * **Trial period for lateral wedges:** A 4–6 week trial with stopping if knee pain does not improve limits exposure to the discomfort and back or foot pain lateral wedges often cause. * **Race-day choices:** Lightweight, low-profile insoles, or removing orthoses for races, limit the running economy penalty for competitive endurance athletes. * **Scheduled replacement:** Replacing foam insoles every 6–12 months or when visibly compressed maintains offloading and prevents new pressure points. ## Therapeutic Protocol * **Prefabricated-first approach:** Academic podiatry groups (La Trobe University; Hylton Menz, Karl Landorf) use prefabricated contoured insoles first, since custom devices performed similarly in heel pain trials ([Landorf et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16801514/)); custom devices are reserved for deformity or failure. * **Custom functional orthoses:** The traditional podiatric approach (Merton Root lineage) casts or scans the foot to build semi-rigid devices intended to control motion, used for structural deformities, rheumatoid feet and when prefabricated devices fail. * **Strength-first approach:** Foot specialists such as Courtney Conley and Irene Davis emphasize foot strengthening and flexible footwear, using insoles short-term for symptom relief while strength is rebuilt. * **Plantar heel pain regimen:** A best-practice guide ([Morrissey et al., 2021](https://pubmed.ncbi.nlm.nih.gov/33785535/)) places taping, plantar fascia stretching and education at the core, adding shockwave therapy and then custom orthoses for people who do not improve. * **Patellofemoral pain regimen:** Prefabricated orthoses worn about 6 weeks, fitted and heat-molded with comfort as the primary goal, with exercise therapy as the core treatment ([Collins et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18952682/)). * **Diabetic high-risk feet:** Custom pressure-optimized insoles in extra-depth footwear, worn for all steps including indoors, since benefit appeared mainly among adherent wearers ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)). * **Achilles tendinopathy:** In-shoe heel lifts worn in both shoes for 12 weeks, as tested in a randomized trial ([Rabusin et al., 2021](https://pubmed.ncbi.nlm.nih.gov/32988930/)). * **Time of day:** Insoles are worn during all weight-bearing hours; first steps after waking provoke heel pain, so supportive indoor footwear with insoles matters, and unprotected indoor steps undermine diabetic offloading. * **Duration of effect:** Insoles have no half-life; their mechanical effect ends when removed, so there is no single-versus-split dosing, only daily wear time. * **Genetic polymorphisms:** No gene variants guide insole choice; inherited foot shape and joint laxity are assessed clinically instead. * **Sex differences:** No sex-specific dosing exists; footwear differences matter, since narrow fashion shoes limit insole thickness and arch height. * **Age:** Older adults typically use firmer insoles with textured or contoured surfaces for balance and heel cups for fat-pad thinning, with slower break-in for fragile skin. * **Baseline biomarkers:** Monofilament testing, ankle-brachial index and in-shoe pressure measurement determine whether a diabetic foot needs accommodative (soft, pressure-relieving) or functional (semi-rigid) devices. * **Pre-existing conditions:** Rheumatoid arthritis favors custom devices with metatarsal pads and heel support; knee osteoarthritis evidence favors neutral over lateral wedge insoles; neuropathy requires pressure-verified devices. ## Discontinuation & Cycling * **Short-term versus lifelong:** Use for heel pain, kneecap pain or Achilles pain is typically short-term (6–12 weeks, extended if symptoms persist); diabetic offloading for people with previous ulcers is lifelong. * **Withdrawal effects:** No physiological withdrawal occurs; symptoms may return on stopping, and removing diabetic offloading insoles exposes previous ulcer sites to recurrence. * **Tapering:** Strength-first practitioners reduce wear time stepwise over 2–4 weeks while progressing foot and calf strengthening; tapering is not appropriate for diabetic protective insoles. * **Cycling:** No evidence shows that cycling maintains efficacy; alternating insole use with flexible, minimal footwear for low-risk activities is used by strength-first practitioners to maintain foot loading. * **Device replacement:** Foam insoles lose cushioning over months and custom devices wear or crack; periodic replacement is part of continued use rather than a break. ## Sourcing and Quality * **Prefabricated versus custom:** Prefabricated contoured insoles are sold widely and perform similarly to custom devices for heel pain and patellofemoral pain; custom devices suit deformity, rheumatoid feet and diabetic offloading. * **Materials:** EVA (ethylene-vinyl acetate) foam cushions and molds to the foot; polypropylene and carbon fiber give firmer control; soft gels cushion but may impair balance; heat-moldable foams allow in-office customization. * **What to look for:** A firm heel cup, an arch contour matching the foot without pressure points, fit inside the intended shoe without lifting the heel, durable top covers, and a return or adjustment policy. * **Reputable sources:** Widely available prefabricated brands include Formthotics, Superfeet, Powerstep and Vasyli; custom devices come from podiatrists, certified orthotists (orthotic device specialists) and pedorthists (footwear specialists); diabetic devices ideally come with in-shoe pressure verification. * **Third-party testing:** No independent quality certification comparable to supplement testing exists for insoles; durability and shape retention vary widely between products. * **Financial incentives:** Custom devices cost several times more than prefabricated ones, and prescribers often profit from custom sales, while insurers have an incentive to favor cheaper devices; both pressures can shape recommendations. ## Practical Considerations * **Time to effect:** Pressure redistribution is immediate; patellofemoral pain relief appears within about 6 weeks, heel pain benefit mainly at 7–12 weeks, and balance effects of textured insoles are often immediate. * **Common pitfalls:** Choosing soft gel for balance, expecting insoles to correct foot structure, stuffing insoles into narrow shoes, skipping break-in, and paying for custom devices where prefabricated ones perform equally. * **Adherence:** Benefits depend on wearing insoles; in diabetic trials, effects appeared mainly among consistent wearers, and uncomfortable devices such as lateral wedges are worn fewer hours daily. * **Regulatory status:** In the United States, arch supports and foot orthoses are regulated by the Food and Drug Administration as low-risk devices largely exempt from premarket review; Medicare covers therapeutic shoes and inserts for eligible people with diabetes. * **Cost and accessibility:** Prefabricated insoles typically cost US$20–80, while custom orthoses commonly cost US$200–800 and require clinic visits, with variable insurance coverage outside diabetes. ## Interaction with Foundational Habits * **Sleep:** None direct: insoles are worn only while upright. Indirectly, less foot or knee pain may improve sleep comfort; night splints used for heel pain are separate devices, not insoles. * **Nutrition:** Indirect interaction: weight loss reduces plantar loading and heel pain risk, and glycemic control preserves protective sensation in diabetes, both reducing reliance on insoles. No foods are known to alter insole effects. * **Exercise:** Potentiating for walking and training tolerance when pain limits activity, but slightly blunting running economy. Break-in before long runs and pairing insoles with foot and calf strengthening balance these effects. * **Stress management:** None direct: no study shows insoles affect cortisol or stress response. Indirectly, reducing chronic pain may ease stress; no specific timing or technique considerations apply. ## Monitoring Protocol & Defining Success Baseline testing before starting insoles records the problem the device is meant to change: pain during walking, a balance test for older adults and, for people with diabetes, protective sensation, circulation and in-shoe pressure. Foot shape and shoe fit are reviewed so the device suits the footwear it will be used in. Ongoing monitoring follows a set cadence: skin checks daily for the first 2 weeks (indefinitely for numb feet), a symptom and fit review at 2 weeks, reassessment of pain or balance at 6–12 weeks, then every 6–12 months, when devices are inspected for compression or wear. People with diabetes and loss of sensation are typically reviewed every 1–3 months, with in-shoe pressure rechecked after any device change. | Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes | |-----------|--------------------------|-----------------|---------------| | Walking pain (0–10 numeric rating scale) | No established target; aim for 0–2, or a drop of at least 2 points from the individual's own baseline | Tracks the main benefit | Record first-step morning pain for heel pain; compare at 6 and 12 weeks | | Timed Up and Go | Under 10 seconds | Balance and mobility | Conventional fall-risk cutoff is 13.5 seconds or more; test in usual shoes with and without insoles | | 10 g monofilament sensation | All tested sole sites felt | Detects loss of protective sensation | Conventional screening flags neuropathy when any site is missed; repeat at least yearly, more often if abnormal | | In-shoe peak plantar pressure | Below 200 kPa at high-risk sites | Verifies offloading | kPa: kilopascals; requires an in-shoe pressure system; recheck after device changes | | HbA1c | 4.8–5.4% | Glycemic control drives neuropathy and ulcer risk | HbA1c: glycated hemoglobin; conventional diabetes target below 7%, normal below 5.7%; no fasting needed; every 3–6 months in diabetes | | Ankle-brachial index | 1.0–1.3 | Confirms circulation adequate for rigid devices | Conventional normal range 0.9–1.4; below 0.5 indicates critical ischemia; measured after 10 minutes lying down | Qualitative markers of success: * Walking distance or daily steps without foot, knee or heel pain * Morning first-step heel pain * Comfort and willingness to wear the insoles all day * Confidence and steadiness on stairs and uneven ground * Absence of blisters, persistent redness or new calluses * Ability to complete training sessions without symptom flares ## Emerging Research * **Sensor-equipped insoles for diabetic ulcer prevention:** WIREDUP ([NCT05950659](https://clinicaltrials.gov/study/NCT05950659)) is randomizing 400 high-risk adults to a commercial sensory insole system plus standard care versus standard care alone, primary endpoint plantar ulcer recurrence. It follows a 90-person trial of alerting insoles, co-funded by the manufacturer, that reduced ulcers ([Abbott et al., 2019](https://pubmed.ncbi.nlm.nih.gov/33323253/)). * **Orthoses plus balance training for falls:** A Cairo University trial ([NCT06615089](https://clinicaltrials.gov/study/NCT06615089)) plans to enroll 60 older adults to test balance training with foot orthoses, primary outcome balance; fall outcomes remain the missing piece for insole research in aging. * **Textured insoles in knee osteoarthritis:** A randomized trial ([NCT07097649](https://clinicaltrials.gov/study/NCT07097649)) compares lateral wedge textured insoles with flat insoles for 4 weeks in 44 older adults, measuring Timed Up and Go, chair-stand performance, balance and plantar pressure. * **Sham-controlled custom orthoses for forefoot pain:** A participant- and assessor-blinded trial ([NCT06962475](https://clinicaltrials.gov/study/NCT06962475)) randomizes 64 people with chronic metatarsalgia (ball-of-foot pain) to custom orthoses with metatarsal pads or sham devices, primary outcome walking pain. * **Exercise versus orthoses for heel pain:** TREADON (registered in the ISRCTN UK trial registry as [ISRCTN12418153](https://www.isrctn.com/ISRCTN12418153); no ClinicalTrials.gov ID) will randomize up to 696 adults across four arms of advice, exercise, prefabricated orthoses or both, and could confirm or remove orthoses' added value ([Thomas et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40487134/)). * **Insole design for balance:** Meta-regression (analysis linking study features to effect size) links arch-support structures and site-specific protrusions to larger balance effects ([Jor et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40998603/)); vibrating insoles reduced sway in older adults ([Priplata et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14550702/)) and improved gait speed in diabetic neuropathy ([Orlando et al., 2024](https://pubmed.ncbi.nlm.nih.gov/38536962/)). * **Evidence that could weaken the case:** Minimalist footwear strengthened foot muscles as effectively as exercise ([Ridge et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30113521/)); head-to-head trials of strengthening versus orthoses, and further null results like those for lateral wedges ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)), could shift practice away from support. ## Conclusion Insoles are simple mechanical devices that change how the foot meets the ground, and for a health-focused adult their value depends on the reason for wearing them. The strongest evidence concerns protection of numb feet in people with diabetes, where pressure-relieving insoles that are actually worn lower the chance of new foot wounds. Whether shaped insoles prevent overuse injuries and bone stress cracks under heavy training loads is disputed, as pooled studies disagree. Benefits for heel pain, kneecap pain, foot pain from inflammatory arthritis and Achilles pain are real but modest and mostly short-lived, and off-the-shelf shaped insoles generally perform as well as costly custom ones. For inner-knee arthritis and back pain, the evidence does not show reliable benefit over plain flat insoles. Balance findings in older adults are encouraging but rest largely on immediate laboratory effects rather than long-term fall prevention. The main downsides are rubbing, blisters and discomfort while adjusting, a small energy cost for runners, and poorer standing balance with very soft cushioning; the concern that support weakens foot muscles remains unproven either way. Much of the research comes from podiatry groups whose profession prescribes these devices, newer sensor-insole studies are partly funded by manufacturers, and insurers have an incentive to favor cheaper options. Taken together, the evidence presents insoles as a targeted tool for specific foot, knee and diabetic problems rather than a general longevity measure. **[Top](#top) - [Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol)**